Ratio of ''Central Venous-to-Arterial Co2 Gap'' to ''Arterial-to-Central Venous O2 Content Gap'' in Septic Shock
Role of "Central Venous-to-Arterial Carbon Dioxide" to "Arterial-to-Central Venous Oxygen Content" Ratio, as a Marker of Anaerobic Metabolism in Septic Shock
1 other identifier
observational
50
1 country
1
Brief Summary
The high ratio of "central venous to arterial carbon dioxide" to "arterial to central venous oxygen content " is associated with elevated lactate in patients with septic shock. So, the aim of the present study is to evaluate the ratio of "central venous-to-arterial CO2 tension or content" to "arterial-to-venous O2 content'' as an indicator of anaerobic metabolism in septic shock.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2020
CompletedFirst Posted
Study publicly available on registry
June 11, 2020
CompletedStudy Start
First participant enrolled
July 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedAugust 23, 2021
August 1, 2021
1.4 years
June 6, 2020
August 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the change of the ratio of "central venous-to-arterial CO2 tension or content" to "arterial-to-central venous O2 content" as an effective marker to indicate anaerobic metabolism in septic shock.
To evaluate the change of the ratio of "central venous-to-arterial CO2 tension or content" to "arterial-to-central venous O2 content" between immediately before and Immedialey after volume expansion to indicate anaerobic metabolism in septic shock.
Measurements will be taken immediately before and immediately after volume expansion
Study Arms (2)
VO2 ≥15 %
This group is classified based on increased oxygen consumption (VO2) ≥15 % by volume expansion in fluid responders
VO2 <15 %
This group is classified based on increased oxygen consumption (VO2) \< 15 % by volume expansion in fluid responders
Interventions
500 ml Fluid challenge of (0.9 % NaCl) will be given
Eligibility Criteria
Critically ill patients who will be admitted to intensive care units and eligible for the study.
You may qualify if:
- Age \>18 years.
- Suspected infection focus
- Mean blood pressure \<65 mmHg, or required vasopressor infusion.
- Lactic acid level \>2 mmol/l.
- Mechanically ventilated patients.
You may not qualify if:
- Age equal or less than 18 years.
- Pregnant women.
- Liver cirrhosis Child-Pugh C.
- Chronic obstructive pulmonary disease.
- Previous episode of septic shock within the last 3 months.
- Patients with a contraindication to volume expansion.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AinShams
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ahmed A Elsawy, Master
Ain Shams University
- STUDY DIRECTOR
Ayman M Kamaly, Professor
Ain Shams University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 6, 2020
First Posted
June 11, 2020
Study Start
July 20, 2020
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
August 23, 2021
Record last verified: 2021-08